Found 6 matching trials
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
PHASE3A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of ampreloxet...
Location
Banner Sun Health Research Institute
Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
PHASE1A double-blind study to characterize the effect of ampreloxetine on cardiac...
Location
Theravance Biopharma Investigational Site
A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
PHASE2The safety and efficacy of multiple dosages of TD-9855, administered once d...
Location
Florida Clinical Research Center, LLC
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
PHASE3This is a Phase 3, multi-center, randomized withdrawal study to evaluate th...
Status
Active Not Recruiting
Location
Movement Disorders Center of Arizona
Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
PHASE3A Phase 3 study to evaluate efficacy, safety, and tolerability of ampreloxe...
Location
Banner Sun Health Research Institute
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
PHASE2This multiple-center, 3-part, single-blind dose escalation (Part A), random...
Location
Theravance Biopharma Investigational Site